Systemic lupus erythematosus in children in Israel

R. Brik*, S. Padeh, M. Mukamel, P. Navon, Y. Uziel, P. Kornmehl, D. Taub, Y. Barash

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Systemic lupus erythematosus (SLE) is a rare disease in children that might possibly be modulated by genetic and environmental factors. In order to delineate the characteristic features of SLE among Israeli children, we reviewed the medical records of 38 cases from 8 pediatric rheumatology clinics. All fulfilled the 1982 American Rheumatism Association revised criteria for SLE. The illness became apparent at the age of 16 years or younger and the mean age of onset was 11.9 +/- 2.4 y (range 7-16) and the mean duration of follow-up 4.0 +/- 4.8 y (range 0.5-15). The female to male ratio was 2.8:1; 28 were Jewish and 10 Arabs. Systemic complaints, such as fever, malaise and weight loss, were noted in 90%, malar rash in 65%, and other skin manifestations in 40%. Arthritis was noted in 57% and additional musculoskeletal complaints in 70%; 90% had hematological abnormalities. Major organ system involvement included: renal disease in 50% pulmonary involvement 28% and CNS involvement 28%. 2 patients are currently on renal dialysis and 1 died from hypertensive crisis. We conclude that the features of SLE in children in Israel are not influenced by ethnic or geographic factors, and are similar to those reported worldwide.

Original languageEnglish
Pages (from-to)233-235, 296, 295
Issue number7-8
StatePublished - Oct 1995
Externally publishedYes


Dive into the research topics of 'Systemic lupus erythematosus in children in Israel'. Together they form a unique fingerprint.

Cite this